A clinically validated human saliva metatranscriptomic test for global systems biology studies

Area of Science:

• Microbiology
• Genomics
• Biotechnology

Background:

• Saliva-based diagnostics are emerging as a non-invasive alternative to blood tests.
• Current methods for analyzing RNA in saliva face challenges with preservation, transportation, and cost.
• Metatranscriptomics offers insights into microbial community function but requires robust sample handling.

Purpose of the Study:

• To develop a high-throughput, automated, and cost-effective saliva metatranscriptome test.
• To ensure RNA preservation and sample safety for ambient-temperature logistics.
• To facilitate global-scale systems biology studies and accelerate precision medicine.

Main Methods:

• Development of a novel RNA preservative for saliva samples.
• Automation of the RNA extraction and preservation process.
• Clinical validation of the saliva metatranscriptome test using minimal sample volumes (<100 μl).

Main Results:

• The developed test is high-throughput, automated, inexpensive, and clinically validated.
• RNA is preserved for up to 28 days at ambient temperatures, allowing for simplified logistics.
• The RNA preservative inactivates pathogens, rendering samples non-infectious and safe for shipping.

Conclusions:

• This saliva metatranscriptome test provides a convenient, safe, and cost-effective solution for large-scale biological studies.
• The test's features support longitudinal studies and the development of novel diagnostic and therapeutic tools.
• Integration into global health initiatives can accelerate the advancement of precision medicine.